Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-4700

TMD8-BTK-HiBiT-KI-1B1-Cell Line

Home » TMD8-BTK-HiBiT-KI-1B1-Cell Line

Background of TMD8-BTK-HiBiT-KI-1B1-Cell Line

The BTK (Bruton's Tyrosine Kinase) gene plays a crucial role in B-cell development and function. Mutations in the BTK gene are associated with X-linked agammaglobulinemia (XLA), a primary immunodeficiency disorder characterized by the absence of mature B cells and low levels of immunoglobulins. BTK is involved in signaling pathways that regulate B-cell proliferation, differentiation, and survival. Recent research has highlighted the potential of BTK inhibitors in treating B-cell malignancies and autoimmune diseases. Understanding the molecular mechanisms of BTK signaling offers promising therapeutic targets for various immune-related conditions.

Specifications

Catalog Number:
KC-4700
Cell Line Name:
TMD8-BTK-HiBiT-KI-1B1-Cell Line
Clone Number
Host Cell Line:
TMD8
Description:
Stable TMD8 cell clone expressing endogenous C-terminal HiBiT tagged BTK, No.1B1
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% RPMI1640+20% FBS+10% DMSO
Propagation Medium:
RPMI1640+10% FBS
Selection Marker:
N/A
Morphology:
lymphoblast
Subculture:
Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 30 hours
Mycoplasma Status:
Negative
In Vivo Validation:

Cell Line Generation

TMD8-BTK-HiBiT-KI-1B1 cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of TMD8-BTK-HiBiT-KI-1B1 Cell Line stable clone using PCR sequencing.

Figure 2: Characterization of TMD8-BTK-HiBiT-KI-1B1 Cell Line stable clone using RT-PCR sequencing.

Figure 3: Characterization of Dose-response curves for TMD8-BTK-HiBiT-KI-1B1 cells treated with PROTAC.

Cell Resuscitation

1. Prewarm culture medium (RPMI1640+10% FBS)in a 37°C water bath.
2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
7. Incubate the flask at 37°C, 5% CO2 incubator.
8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
2. Keep the freezing medium on ice and label cryovials.
3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
6. Aliquot 1 mL of the cell suspension into each cryovial.
7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
8. Transfer vials to liquid nitrogen for long-term storage.

References

1.Vetrie, D., et al. (1993). The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature, 361(6409), 226-233.
2.Mohamed, A. J., et al. (2009). Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. Immunological Reviews, 228(1), 58-73.
3.Pal Singh, S., et al. (2018). Role of Bruton's tyrosine kinase in B cells and malignancies. Molecular Cancer, 17(1), 57.